Authors

• Nancy Cross
• Melinda Gooderham (ORCID: https://orcid.org/0000-0001-8926-0113)
• Ulrich Mrowietz (ORCID: https://orcid.org/0000-0002-9539-0712)
• Andreas Pinter (ORCID: https://orcid.org/0000-0002-1330-1502)
• Boni E. Elewski (ORCID: https://orcid.org/0000-0002-1475-2874)
• Stefano Piaserico (ORCID: https://orcid.org/0000-0002-1091-4733)
• Joseph Frank Merola (ORCID: https://orcid.org/0000-0001-6514-4353)
• Susanne Wiegratz
• Alice Bendix Gottlieb (ORCID: https://orcid.org/0000-0002-2927-8618)
• Krista Wixted
• Nicola Tilt
• Richard Bruce Warren (ORCID: https://orcid.org/0000-0002-2918-6481)

Institutions

• Goethe University Frankfurt (DE)
• University of Padua (IT)
• Queen's University (CA)
• University Hospitals of Cleveland (US)
• Manchester Academic Health Science Centre (GB)
• Northern Health and Social Care Trust (GB)
• Manchester University NHS Foundation Trust (GB)
• Southwestern Medical Center (US)
• Probity Medical Research (CA)
• University Hospital Frankfurt (DE)
• NIHR Manchester Biomedical Research Centre (GB)
• Clinical Research Center Kiel (DE)
• UCB Pharma (Germany) (DE)
• Southwestern Medical Center (US)
• Case Western Reserve University (US)
• The University of Texas Southwestern Medical Center (US)
• Icahn School of Medicine at Mount Sinai (US)

Publication Details

Journal

Dermatology and Therapy

Published

2024-11-22

DOI

https://doi.org/10.1007/s13555-024-01295-w

Citations

11

Primary Topic

Psoriasis: Treatment and Pathogenesis

Type

article

Field-Weighted Citation Impact

2.65

Funders

• Bristol-Myers Squibb
• Eli Lilly and Company
• Sanofi
• XBiotech
• National Institute for Health and Care Research
• Manchester Biomedical Research Centre
• UCB Pharma